DUSA Pharmaceuticals
This article was originally published in The Gray Sheet
Executive Summary
Maker of Levulan photodynamic therapy and photodetection products receives FDA "approvable" letter for a PMA supplement for a commercial version of its BLU-U light source for use in conjunction with the Levulan Kerastick actinic keratoses therapy for the face and scalp. A BLU-U prototype gained approval in December 1999 in conjunction with a new drug application for Levulan (1"The Gray Sheet" Dec. 13, 1999, p. 17)